Cystic Fibrosis Foundation
Biotech Investor · 6 portfolio companies
Portfolio
6
Combined Value
$502.3M
Focus Areas
19
Top Stage
Pre-clinical
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| 4D Molecular Therapeutics | $496.1M |
| Beyond Air | $6.2M |
| Carbon Biosciences | — |
| Owlstone Medical | — |
| Spirovant Sciences | — |
| Avecris | — |